Attendees

Mr John Feneley (Chair), Professor Alan Rosen, Ms Judith Mackson, Prof Andrew McLachlan, Ms Kerin O’Halloran, Dr Titia Sprague, Ms Sam Stott, Dr Michael Tam, A / Prof Timothy Wand, Dr Murray Wright

Apologies

A / Prof Timothy Chen, Mr Carlton Quartly

Guest

Ms Erin O'Loughlin

Secretariat

Ms Danielle Keogh

1. Welcome and apologies

The Commissioner welcomed members.  The apologies of A/Prof Tim Chen and Mr Carlton Quartly were accepted. 

2. Minutes from previous meeting

The minutes of the meeting held 8 October 2015 were accepted. 

3. Commissioner update

The Commissioner advised the group that the One Year on Report, on the implementation of Living Well: A strategic plan for metal health in NSW, was submitted to the NSW Minister for Mental Health, The Hon. Pru Goward. In February the Minister tabled the report in parliament.

One year on focuses on the preparations agencies have made to better support the people of NSW by strengthening community based responses to mental health needs and to shift our system from acute crises towards prevention and earlier intervention. 

4. Medication and mental illness paper and film

Erin O’Loughlin, Communications Advisor, NSW Mental Health Commission, presented to the group the communications plan for the medication paper and film that has been active since the 2 December 2015 launch.

Highlights include: stories in Psychiatry Update, Australian Doctor, 6Minutes, and potential use of the depression film by NPS in treating depression in general practice campaign.  

The group shared their individual efforts to distribute the paper and film amongst colleagues and networks. For example Sam Stott told the group that the paper is now used in the South Eastern Sydney Recovery College medication course.

The group agreed that the paper and films were a good resource and that the messages within should be exploited further.

5. Opportunities for the Commission to leverage change

The group discussed ways the Commission could use the medication paper and films to promote change. The group agreed that the Commission should consider developing a ‘postcard’ with the paper’s key messages, that consumers can hand to their clinicians to start a conversation about the quality use of medicines in their treatment. The Commission will test this idea with a group of consumers.  

6. Any other business

The group discussed pharmacogenomics. Discussion included that the results from pharmacogenmoic testing can be useful. The tests may influence decision-making about type of medication, dose and frequency of administration. However it was also noted that these tests should not solely be relied on for decision making about medicines. Other factors that should influence decision making include the person’s goals, the person’s lived experience of medications, complexity of medication regimes, and costs of medication. 

7. Next meeting

Monday, 12 September 2016, 4pm – 6pm, NSW Mental Health Commission, Gladesville. 

 

 

Share this

Share on Facebook Share on Twitter Share on Google+ Share on LinkedIn E-mail More
Last updated: 3 June 2017